Canntab Therapeutics Limited CTABF
0.00 USD 0.00 (+0.00%)
At closeNov 28, 2025, 4:00 PM EST
0.0001 Day range 0.0073
0.0001 52-week range 0.0073
News
newsfilecorp.com CSE Bulletin: Delist - Canntab Therapeutics Limited (PILL) Toronto, Ontario--(Newsfile Corp. - le 14 juin/June 2024) - The common shares of Canntab Therapeutics Limited will be delisted from the CSE at market close today, June 14, 2024. Canntab Therapeutics…
newsfilecorp.com Canntab Therapeutics Limited Provides Update on Application for Management Cease Trade Order Toronto, Ontario--(Newsfile Corp. - September 18, 2023) - Canntab Therapeutics Limited (CSE: PILL) (OTC Pink: CTABF) (FSE: TBF1) (the "Corporation") announces that the Ontario Securities Commission…
proactiveinvestors.com Canntab Therapeutics seeks to move manufacturing process as Markham lease expires Canntab Therapeutics Ltd (CSE:PILL, OTCQB:CTABF) has provided an update on several matters impacting the company, including plans to move its manufacturing operations following expiry of its lease at…
proactiveinvestors.com Canntab Therapeutics provides update on recent product delivery of its cannabinoid solutions to the Nova Scotia Liquor Corporation Canntab Therapeutics Limited has provided an update on the recent product delivery of its unique pharmaceutical cannabinoid solutions to the Nova Scotia Liquor Corporation (NSLC). The company said…
proactiveinvestors.com Canntab Therapeutics appoints Hamish Sutherland as strategic business consultant Canntab Therapeutics Ltd said it has appointed Hamish Sutherland as a strategic business consultant to develop additional sales and distribution channels for the company's products and to assist it…
proactiveinvestors.com Canntab Therapeutics inks affiliate deal with independent pharmacy owners in Ontario Canntab Therapeutics Ltd (CSE:PILL, OTCQB:CTABF) announced that it has entered into an affiliate agreement with OnPharm-United, a 600-plus network of independent pharmacy owners throughout the…
proactiveinvestors.com Canntab Therapeutics closes non-brokered private placement of secured convertible debentures for gross proceeds of $1,312,000 Canntab Therapeutics Ltd (CSE:PILL, OTCQB:CTABF) said it has closed a non-brokered private placement of secured convertible debentures of the company, under which the company issued and will issue…
benzinga.com Levitee Labs Teams Up With Canntab Therapeutics, Offer Cannabinoid Products As Alternatives To Opioids Wellness company Levitee Labs Inc. (CSE:LVT) (OTC:LVTTF) (FSE:7H7) confirmed Monday that it has teamed up with cannabinoid company Canntab Therapeutics Limited (CSE:PILL) (OTCQB:CTABF) (FRA: TBF1.F).…
benzinga.com Canntab Therapeutics Completes First Shipment Of THC Tablets To Ontario Cannabis Stores Canntab Therapeutics Limited (CSE:PILL) (OTCQB:CTABF) (FRA: TBF1.F), an innovator in cannabinoid and terpene blends, said Monday that it has completed its first shipment of 5 mg THC tablets to the…
proactiveinvestors.com Levitee Labs partners with Canntab Therapeutics to provide alternative to drugs amid opioid crisis in Canada Levitee Labs (CSE:LVT) Inc said it has entered into a strategic partnership via a service agreement with Canntab Therapeutics Limited to contribute towards correcting the opioid crisis in Canada.…
proactiveinvestors.com Canntab Therapeutics provides an update on its recent product deliveries for Ontario and Australia Canntab Therapeutics Limited, a leading innovator in cannabinoid and terpene blends in hard pill form, provided an update on its successful product deliveries for Ontario and Australia, which augur…
proactiveinvestors.com Pathway Health and Canntab Therapeutics strike agreement to provide oral tablet cannabinoid products in select Canadian pharmacies Pathway Health (TSX-V:PHC) Corp and Canntab Therapeutics Limited are teaming up to deliver Canntab's oral tablet cannabinoid products within Pathway's pharmacy network. The products will consist of a…
proactiveinvestors.com Canntab Therapeutics receives medical sales license from Health Canada for its Ontario facility Canntab Therapeutics Limited said it has received its medical sales license from Health Canada for its Markham, Ontario facility, enabling the sale of all products directly to medical consumers. The…
proactiveinvestors.com Canntab Therapeutics reaches agreement with 36Eight Technologies to provide effective medical solutions for patients Canntab Therapeutics Limited announced that it has reached an agreement with 36Eight Technologies Inc — a bioinformatics pharmacological healthcare data and technology company — to help the cannabis…
prnewswire.com Canntab Reaches Agreement with Innovative Bioinformatics Company, 36eight Technologies Inc. TORONTO, Oct. 18, 2021 /PRNewswire/ - Canntab Therapeutics Limited (CSE: PILL.CN) (OTCQB: CTABF) (FRA: TBF1.F) (the "Company" or "Canntab"), the leading innovator in cannabinoid and terpene blends in…
proactiveinvestors.com Dow pulls to above the flatline after morning struggles as traders digest jobs data 12:30pm: Nasdaq finds little upward momentum The Dow clawed its way out of an early deficit to 15 points higher at midday at 34,615. The Nasdaq was down 117 points, 0.9%, at 13,641, and the S&P 500…
proactiveinvestors.com Canntab Therapeutics brings in C$1,259,250 gross from early exercise of warrants Canntab Therapeutics Limited (CSE:PILL) (OTCQB:CTABF) (FRA:TBF1), the biopharma focused on hard pill cannabis formulations, said it had received C$1,259,250 gross from the early exercise of warrants.…
prnewswire.com Canntab Announces the Early Exercise of $1,259,250 Warrants TORONTO, June 3, 2021 /PRNewswire/ - Canntab Therapeutics Limited (CSE: PILL.CN) (OTCQB: CTABF) (FRA: TBF1.F) (the "Company" or "Canntab"), the leading innovator in cannabinoid and terpene blends in…
proactiveinvestors.com Canntab Therapeutics receives export license from Health Canada Canntab Therapeutics Limited (CSE:PILL) (OTCQB:CTABF) (FRA:TBF1) said it has been granted an export license by Health Canada. The maker of hard pill cannabinoid formulations said it can now fulfill…
prnewswire.com Canntab Receives Export License Approval from Health Canada TORONTO, March 30, 2021 /PRNewswire/ - Canntab Therapeutics Limited (CSE: PILL.CN) (OTCQB: CTABF) (FRA: TBF1.F) (the "Company" or "Canntab"), a leading innovator in cannabinoid and terpene blends in…
benzinga.com Stocks That Hit 52-Week Lows On Thursday 
benzinga.com New 52-Week Lows For Monday Morning